Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 307 - Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
Patents for C07C 307 - Amides of sulfuric acids, i.e. compounds having singly-bound oxygen atoms of sulfate groups replaced by nitrogen atoms, not being part of nitro or nitroso groups (1,726)
07/2005
07/28/2005US20050165240 Chemical intermediates for production of sibutramine
07/27/2005CN1212311C Acrylonitrile compounds, process for their prodn, and pesticides containing them
07/21/2005WO2005065361A2 Compounds and compositions for treating dysproliferative diseases, and methods of use thereof
07/21/2005US20050159622 Reacting a primary or secondary amine with of SO3 or a source in the presence of a tert-amine and reacting the sulfamate formed with a phosphorus halide; the product may be reacted with NH3 to form the sulfamide, the NH2 group of which may then be acylated with a N-heterocycl-N-ylbenzoyl derivative
07/19/2005US6919450 Process for the preparation of benazepril
07/14/2005WO2005063222A1 Hsp90 FAMILY PROTEIN INHIBITOR
07/14/2005WO2005063018A1 Haloalkene compounds, process for their production and pesticides containing them
07/14/2005WO2005035514A3 Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups
07/14/2005WO2004113277A8 Methods and compositions for treating amyloid-related diseases
07/14/2005US20050154011 such as S)-3-Methylcarbamoyl-7-sulfoamino-3,4-dihydro-1H-isoquinoline-2-carboxylic acid tert-butyl ester, used in the treatment of protein tyrosine phosphatase (PTPase) mediated disorder such as diabetes
07/13/2005EP1311490A4 Amino acid-derived, 7-membered cyclic sulfamides and methods of synthesizing the same
07/12/2005CA2238859C Amino acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them
07/07/2005US20050148648 Cystic fibrosis transmembrane conductance regulator; ABC transporter mediated diseases like cystic fibrosis; 5-methoxy-N-((1-(3,4-dimethoxyphenyl)-cyclohexyl)methyl)benzofuran-2-carboxamide; or sulfonamide analogs; chloride or bicarbonate channel modulators
07/05/2005CA2119572C Oxygen substituted derivatives of nucleophile-nitric oxide adducts as nitric oxide donor prodrugs
06/2005
06/30/2005WO2005058806A1 Method for producing chlorosulfonyl isocyanate
06/30/2005WO2002058698A8 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
06/29/2005EP1395550B1 Cycloalkenylsulfonamide derivatives
06/29/2005CN1208329C Aniline derivatives
06/28/2005CA2114746C Substituted triazolinones
06/22/2005CN1207268C Novel derivatives of 3-3-diphenylpropylamines
06/14/2005US6906094 1,2,4-tribsubstituted benzenes as inhibitors of 15-lipoxygenase
05/2005
05/31/2005US6900353 Cyclopentyl sulfonamide derivatives
05/25/2005CN1202815C Delayed-action form of administration containing tramadol saccharinate
05/19/2005WO2005044787A1 Phenetanolamine derivatives
05/11/2005CN1200700C Pharmaceutical tramadol salts
05/10/2005US6890932 Anthranilic acid derivative
05/05/2005US20050096385 reduces or inhibits amyloid fibril formation, organ specific dysfunction (e.g., neurodegeneration), or cellular toxicity
05/04/2005EP1528055A2 Sulphonamide Derivatives
05/04/2005CN1612729A 2-aryl-propionic acid and medicine composition containing same
04/2005
04/28/2005WO2005037776A1 Novel molecule for inducing differentiation of dendritic cells
04/28/2005WO2005037775A1 Novel molecule for inducing differentiation of dendritic cells
04/28/2005WO2005037774A1 Novel molecules to develop drug for the treatment of osteoporosis
04/21/2005WO2005035514A2 Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups
04/21/2005US20050085547 Molecules for inducing differentiation of dendritic cells
04/21/2005US20050085546 Method of inducing differentiation of dendritic cells
04/21/2005US20050085537 Method and composition for treating osteoporosis
04/21/2005US20050085461 Benzenesulfonamide derivatives
04/21/2005CA2540978A1 Modulators of atp-binding cassette transporters containing cycloalkyl or pyranyl groups
04/13/2005EP1522543A1 Use Steroid sulphatase inhibitors for the manufacture of a medicament for the treatment of an oestrogen dependent tumour
04/06/2005EP1519915A2 Tricyclic steroid hormone nuclear receptor modulators
03/2005
03/30/2005CN1602191A Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
03/15/2005US6867320 Prostaglandin inhibitor; suppression leukotriene; antiinflammatory agents; rheumatic diseases
03/08/2005US6864392 α-Sulfin and α-Sulfonamino amide derivatives
02/2005
02/24/2005WO2005016862A1 Substituted arylalkanoic acid derivative and use thereof
02/24/2005CA2535665A1 Substituted arylalkanoic acid derivative and use thereof
02/23/2005EP1507504A1 Cycloalkyl inhibitors of potassium channel function
02/23/2005CN1585744A Process for the preparation of benazepril
02/22/2005US6858651 2,3-oxidosqualene-lanosterol cyclase inhibitors
02/17/2005WO2004113278A3 Acylsulfamide inhibitors of factor viia
02/17/2005US20050038119 for treatment of neutrofil-dependent pathologies such as psoriasis, ulcerative colitis, melanoma, chronic obstructive pulmonary disease (COPD), bollous pemphigo, rheumatoid arthritis, idiopathic fibrosis, glomerulonephritis; prevention and treatment of damages caused by ischemia and reperfusion
02/17/2005US20050038117 reduces or inhibits amyloid fibril formation, organ specific dysfunction (e.g., neurodegeneration), or cellular toxicity
02/16/2005EP1506169A1 Method for the production of sulphamic acid halogenides
01/2005
01/26/2005CN1186332C New thryoid receptor ligands and process II
01/19/2005EP1497272A2 Method of preparing amine stereoisomers
01/19/2005EP1497261A1 Phenethanolamine derivatives
01/12/2005EP1495004A2 Benzenesulfonamide derivatives and their use as dopamine d3 and d2 receptor ligands
01/06/2005US20050004043 Protease inhibitors; human t-cell leukemia virus; aids
12/2004
12/29/2004WO2004113278A2 Acylsulfamide inhibitors of factor viia
12/29/2004WO2004113277A2 Methods and compositions for treating amyloid-related diseases
12/29/2004WO2004113275A2 Methods and compositions for treating amyloid-related diseases
12/29/2004CN1181825C Use of colchinol derivatives in preparation of vascular damaging agents drug
12/29/2004CA2529257A1 Methods and compositions for treating amyloid-related diseases
12/29/2004CA2529256A1 Methods and compositions for treating amyloid-related diseases
12/16/2004WO2003063797A8 Cycloalkyl inhibitors of potassium channel function
12/16/2004US20040254241 Enzyme inhibitor; cognition activators
12/16/2004US20040254237 Acid amide derivatives, process for producing these, and pest agent containing these
12/09/2004WO2004080389A3 Hydroxyeicosadienamide compounds
12/09/2004WO2004062594A3 Antineoplastic ether lipid compounds with modifications at the sn-3 carbon
12/08/2004EP1484313A1 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase
12/02/2004US20040242585 Acylsulfamide inhibitors of factor VIIa
11/2004
11/18/2004WO2004099126A1 N-(2-PHENYLETHYL)SULFAMIDE DERIVATIVES AS INTEGRIN α4 ANTAGONISTS
11/18/2004CA2524235A1 Phenyl substituted carboxylic acids as inhibitors of protein tyrosine phosphatase-1b
11/17/2004EP1477472A1 Substituted phenylalkanoic acid derivative and use thereof
11/02/2004CA2094806C Aminosulfonyl urea acat inhibitors
10/2004
10/28/2004US20040214721 Controlling or preventing the infestation of plants by phytopathogenic microorganisms and fungi
10/27/2004CN1539816A IL-8 receptor antagonist
10/14/2004WO2004087720A1 Phosphate/sulfate ester compounds and pharmaceutical compositions for inhibiting protein interacting nima (pin1)
10/14/2004CA2517281A1 Phosphate/sulfate ester compounds and pharmaceutical compositions for inhibiting protein interacting nima (pin1)
10/13/2004EP1207866B1 Delayed-action form of administration containing tramadol saccharinate
10/13/2004CN1537001A Malonyl-COA decarboxylase inhibitors useful as metabolic modulators
10/06/2004EP1101755B1 Anthranilic acid derivatives
09/2004
09/23/2004WO2004080389A2 Hydroxyeicosadienamide compounds
09/23/2004US20040186298 Novel use of sulfamic acids as resolving agent
09/23/2004US20040186061 Novel derivatives of 3,3-diphenylpropylamines
09/22/2004EP1458375A2 Compositions for decreasing activity of hormone-sensitive lipase
09/22/2004EP1458374A2 Compounds and uses thereof for decreasing activity of hormone-sensitive lipase
09/16/2004WO2003091207A3 Method of preparing amine stereoisomers
09/15/2004EP1456224A2 Industrially applicable process for the sulfamoylation of alcohols and phenols
09/15/2004EP1455773A1 2-aryl-propionic acids and pharmaceutical compositions containing them
09/15/2004EP1077925B1 Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase
09/10/2004WO2004052847A3 Tricyclic steroid hormone nuclear receptor modulators
09/09/2004US20040176595 Glucocorticoid receptor modulators
09/09/2004US20040176267 Carbonylsulfamide and carbonylsulfoxamide derivatives; producing organic sterilizing agents when combined with such as percarbonate or perborate compound in aqueous medium; disinfecting medical equipment, air conditioner interiors, foodstuffs, plants, animal enclosures
09/02/2004WO2004074256A1 Tetrahydroisoquinolinyl sulfamic acids
09/02/2004WO2004074238A1 Phenethylamino sulfamic acids
09/02/2004US20040171653 HIV, AIDS; such as 2-[[(dimethylamino)acetyl]amino]-N-[3-[[[(2-hydroxy-1,1-dimethylethyl)amino]sulfonyl](3-methylbutyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-3,3-dimethylbutanamide
08/2004
08/26/2004US20040167183 Protein tyrosine phosphatase inhibitor; antidiabetic agents; hypotensive agents; cardiovascular disorders; inflammatory bowel disorders; antiulcer agents; wound healing agents; anticancer agents
08/19/2004US20040162228 Novel peracid precursors for antimicrobial use
08/12/2004US20040157817 Cycloalkenylsulfonamide derivatives
08/11/2004CN1520398A Novel N-isaryl-and N-aryl-cycloalkylidenyl-G(a)-sulfin-and G(a)-sulfonamino acid amides
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 ... 18